SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIMONDI, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.120
AS - Asia 3.161
EU - Europa 2.047
SA - Sud America 507
Continente sconosciuto - Info sul continente non disponibili 204
AF - Africa 81
OC - Oceania 7
AN - Antartide 1
Totale 13.128
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.843
SG - Singapore 1.204
CN - Cina 729
IT - Italia 670
BR - Brasile 392
VN - Vietnam 349
DE - Germania 263
HK - Hong Kong 257
PL - Polonia 213
GB - Regno Unito 200
UA - Ucraina 180
TR - Turchia 136
CA - Canada 128
BD - Bangladesh 105
FI - Finlandia 99
FR - Francia 85
SE - Svezia 85
JP - Giappone 83
RU - Federazione Russa 77
IN - India 76
ID - Indonesia 65
AR - Argentina 41
MX - Messico 39
ES - Italia 34
ZA - Sudafrica 34
NL - Olanda 33
IQ - Iraq 28
BE - Belgio 21
VE - Venezuela 21
MY - Malesia 18
PK - Pakistan 18
LT - Lituania 17
HN - Honduras 16
CZ - Repubblica Ceca 15
CO - Colombia 14
EC - Ecuador 14
GT - Guatemala 14
NI - Nicaragua 13
SA - Arabia Saudita 13
CR - Costa Rica 12
UZ - Uzbekistan 12
AT - Austria 11
CW - ???statistics.table.value.countryCode.CW??? 11
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
SV - El Salvador 10
TT - Trinidad e Tobago 10
KG - Kirghizistan 9
MA - Marocco 9
PR - Porto Rico 9
CL - Cile 8
EG - Egitto 8
RO - Romania 8
KE - Kenya 7
AU - Australia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
AZ - Azerbaigian 5
IL - Israele 5
PH - Filippine 5
TN - Tunisia 5
UY - Uruguay 5
DK - Danimarca 4
DZ - Algeria 4
RS - Serbia 4
CI - Costa d'Avorio 3
GP - Guadalupe 3
HR - Croazia 3
IR - Iran 3
KR - Corea 3
NP - Nepal 3
PT - Portogallo 3
SC - Seychelles 3
SN - Senegal 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
CH - Svizzera 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
PE - Perù 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AQ - Antartide 1
Totale 12.921
Salva come PNG Salva come JPEG
Città #
Ashburn 858
Singapore 725
Fairfield 533
San Jose 517
Woodbridge 488
Council Bluffs 384
Santa Clara 295
Houston 285
Beijing 257
Hong Kong 249
Seattle 232
Chandler 218
Warsaw 210
Dallas 208
Ann Arbor 203
Wilmington 198
Ferrara 194
Jacksonville 190
Cambridge 187
New York 136
Ho Chi Minh City 126
Los Angeles 122
Munich 80
Hanoi 78
Tokyo 78
Izmir 64
Milan 60
Princeton 60
Lauterbourg 54
Jakarta 53
São Paulo 49
Nanjing 47
San Diego 43
Montreal 40
Shanghai 37
Helsinki 36
Boardman 35
London 34
Bologna 31
Buffalo 31
Toronto 31
Chicago 28
Denver 27
Rome 26
North Bergen 25
Orem 25
Phoenix 25
Atlanta 22
Brooklyn 22
Frankfurt am Main 22
Johannesburg 22
Chennai 21
Manchester 21
Nanchang 20
Falls Church 19
Boston 18
Brussels 17
Da Nang 17
Hefei 17
Tianjin 17
Mexico City 16
Shenyang 16
The Dalles 16
Turku 16
Bari 15
Dearborn 15
Dong Ket 15
Naples 15
Poplar 15
Washington 15
Haiphong 14
Rio de Janeiro 14
San Francisco 14
Baghdad 13
Managua 13
Moscow 13
Ankara 12
Nuremberg 12
Tashkent 12
Ferrara di Monte Baldo 11
Lappeenranta 11
Stockholm 11
Willemstad 11
Brno 10
Guatemala City 10
San Salvador 10
Auburn Hills 9
Bishkek 9
Campinas 9
Caracas 9
Charlotte 9
Hebei 9
Jiaxing 9
Madrid 9
Mumbai 9
San José 9
San Mateo 9
Verona 9
Bremen 8
Calgary 8
Totale 8.636
Salva come PNG Salva come JPEG
Nome #
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 305
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 300
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 295
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 289
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 285
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 272
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 256
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 244
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 244
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 240
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 235
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 235
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 232
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 230
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 225
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 223
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 223
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 220
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 220
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 213
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 211
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 210
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 203
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 198
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 197
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 196
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 195
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 195
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 191
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 185
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 183
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 183
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 182
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 181
Role of vitamin D in the pathogenesis of atheromatosis 181
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 179
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 178
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 177
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 172
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 170
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 169
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 164
TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release 164
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 161
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 160
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 160
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 158
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 155
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 146
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 143
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 142
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 139
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 138
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 124
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 123
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 120
MitoQ is able to modulate apoptosis and inflammation 116
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 113
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 105
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 105
The role of the mTOR pathway in diabetic retinopathy 101
null 92
null 90
null 90
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 89
null 88
null 86
null 83
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 78
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 77
null 76
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study 75
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 69
null 69
null 55
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 53
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 48
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 47
null 44
null 42
Analytical Profiling of Inflammation-associated Volatile Metabolites: HS-SPME to an in vitro model of Human Skin Fibroblasts 40
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 35
Trained immunity in the inflammatory cascade of chronic inflammatory skin diseases: possible checkpoints and new therapeutic targets 23
SKIN CELL VOLATILOME PROFILING UNDER INFLAMMATORY CONDITIONS: BRIDGING IN VITRO MODELS AND CLINICAL BIOMARKERS 20
Totale 13.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022508 0 0 0 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/20251.604 42 30 132 90 210 126 56 83 306 146 218 165
2025/20265.032 463 283 421 560 693 301 581 284 463 596 244 143
2026/20271.494 129 250 532 583 0 0 0 0 0 0 0 0
Totale 13.128